by Montemurro, Paolo;
Cheema, Mubashir; Hedén, Per; Behr, Björn; Wallner, Christoph
Background: Augmentation mastopexy may be a one- or two-stage procedure. Because of
the opposing force vectors in augmentation and in mastopexy, some surgeons
advocate a two-stage procedure. The literature appears divided on which
operation has a more favorable complication profile. The purpose of this review
was to benchmark the outcomes of single-stage augmentation mastopexy against
those of a commonly performed aesthetic breast operation (primary breast
augmentation).
Methods: The authors reviewed electronic patient records of all consecutive
female patients who underwent single-stage augmentation mastopexy and primary
breast augmentation performed by the first author at our clinic between April
of 2009 and May of 2017 with at least a 6-month follow-up. Data from
single-stage augmentation mastopexy were benchmarked against the outcomes of
primary breast augmentations performed by the same surgeon, for the same
period, and at the same clinic.
Results: One hundred four single-stage augmentation mastopexies and 801 primary
breast augmentations were performed during this period, with mean follow-up of
15.4 months and 14.0 months, respectively. Augmentation mastopexy patients were
significantly more likely to be older, have a higher body mass index, have more
children, and were significantly less likely to use oral contraceptives. There
was no statistically significant difference in overall complication rate between
the two groups.
Conclusions: The authors’ experience suggests that single-stage augmentation
mastopexy has outcomes comparable to those of primary breast augmentation.
Smokers were more likely to undergo reoperation because of postoperative
complication (seroma), but the rate of implant exchange was not different.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
